Back to Search
Start Over
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
- Source :
- The Lancet; February 2022, Vol. 399 Issue: 10324 p521-529, 9p
- Publication Year :
- 2022
-
Abstract
- The inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac, Sinovac) has been widely used in a two-dose schedule. We assessed whether a third dose of the homologous or a different vaccine could boost immune responses.
Details
- Language :
- English
- ISSN :
- 01406736 and 1474547X
- Volume :
- 399
- Issue :
- 10324
- Database :
- Supplemental Index
- Journal :
- The Lancet
- Publication Type :
- Periodical
- Accession number :
- ejs58822646
- Full Text :
- https://doi.org/10.1016/S0140-6736(22)00094-0